Torpedo Therapeutics
Torpedo Therapeutics is dedicated to advancing the field of neurological disorder treatment through high-precision, closed-loop deep brain stimulation (DBS) therapy. Their mission is to enhance the efficacy and safety of DBS by innovating electrode technologies and developing automated data analysis platforms. This approach aims to minimize side effects and improve long-term outcomes for patients with conditions such as Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy.
What We Do
Torpedo Therapeutics develops high-precision DBS devices using micro-and nano-fabrication technologies. These devices feature electrode leads with individual micro-electrodes that can sense neural activity and stimulate with high spatial resolution, achieving single neuron precision.
The company is creating a closed-loop DBS platform that continuously senses neural activity and automatically adjusts stimulation parameters. This reduces the need for frequent re-programming and extends the life of the implanted pulse generator.
Torpedo Therapeutics is developing a machine learning-driven data analysis platform that predicts and adjusts stimulation parameters based on real-time neural activity data.